共 29 条
[1]
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Fard A, Tuck CH, Donis JA, et al. Arteriosclerosis and Thrombosis . 2000
[2]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[3]
Metabolismofmethy largininesbyhumanvasculature:implicationsfortheregulationofnitricoxidesyn thesis. MacAllisterRJ,FicklingSA,WhitleyGS,VallanceP. British Journal of Pharmacology . 1994
[4]
Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Matsuoka H, Itoh S, Kimoto M, et al. Journal of Hypertension . 1997
[5]
StudiesonthecatabolismofNG methylarginine,NG,N’’G dimethy larginineandNG,NG dimethylarginineintherabbit. McDermott. Biochemistry . 1976
[6]
Reducedurinaryexcretionofnitricoxidemetabolitesandincreasedplasmalevelsofasymmetricdimethylarginineinmenwithessentialhypertension. SurdackiS,NowickiM,SandmannJ,etal. JCardiovascPharmacol . 1999
[7]
Accumu lationofendogenousinhibitorsfornitricoxidesynthesisanddecreasedcontentofL arginineinregeneratedendothelialcells. AzumaH,SatoJ,HamasakiH,SugimotoA,IsotaniE,ObayashiS. British Journal of Pharmacology . 1995
[8]
Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Fujiwara N,Osanai T,Kamada T, et al. Circulation . 2000
[9]
Accelerated inti mal hy-perplasia andincreased endogenousinhibitors for NOsynthesisinrabbits with alloxan-induced hyperglycaemia. Masuda H,Goto M,Tamaoki S,et al. British Journal of Pharmacology . 1999
[10]
Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. The American Journal of Cardiology . 2002